McKenna Mark C.

CIK 00017496238 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001749623

Recent Transactions

50 trades

Disposition to Issuer
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2026-09-03−10,370→ 0 total
Disposition to Issuer
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-09-03−20,000→ 0 total
Disposition to Issuer
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2026-09-03−150,000→ 0 total
Disposition to Issuer
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2026-09-03−7,657→ 0 total
Disposition to Issuer
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2026-09-03−14,461→ 0 total
Conversion
Freenome, Inc.$FRNM
Common Stock
2026-07-20+30,000→ 30,000 total
Conversion
Freenome, Inc.$FRNM
Class B Ordinary Shares
2026-07-20−30,000→ 0 total
Award
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2026-06-09+7,657→ 7,657 total
Award
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2026-05-27+8,026→ 8,026 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2026-01-07+15,300→ 15,300 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-07+3,400→ 10,360 total
Exercise/Conversion
BridgeBio Oncology Therapeutics, Inc.$BBOT
Class B ordinary shares
2025-08-11−30,000→ 0 total
Exercise/Conversion
BridgeBio Oncology Therapeutics, Inc.$BBOT
Common Stock
2025-08-11+30,000→ 30,000 total
Award
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2025-06-17+14,461→ 14,461 total
Award
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2025-05-29+25,000→ 25,000 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-01-07+6,960→ 6,960 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2025-01-06+32,500→ 32,500 total
Purchase
Apogee Therapeutics, Inc.$APGE
Common Stock
2024-12-12$49.85/sh+12,500→ 20,000 total
Purchase
Apogee Therapeutics, Inc.$APGE
Common Stock
2024-12-12$49.02/sh+7,500→ 7,500 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2024-07-17+72,500→ 72,500 total
Award
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2024-06-05+10,370→ 10,370 total
Award
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2024-02-01+40,000→ 40,000 total
Award
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2023-08-17+100,000→ 150,000 total
Award
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2023-08-17+50,000→ 50,000 total
Disposition to Issuer
Prometheus Biosciences, Inc.
Stock Option (right to buy)
2023-06-16−246,639→ 0 total
Disposition to Issuer
Prometheus Biosciences, Inc.
Common Stock
2023-06-16−178,098→ 0 total
Disposition to Issuer
Prometheus Biosciences, Inc.
Stock Option (right to buy)
2023-06-16−161,105→ 0 total
Disposition to Issuer
Prometheus Biosciences, Inc.
Stock Option (right to buy)
2023-06-16−132,741→ 0 total
Disposition to Issuer
Prometheus Biosciences, Inc.
Stock Option (right to buy)
2023-06-16−20,000→ 0 total
Disposition to Issuer
Prometheus Biosciences, Inc.
Stock Option (right to buy)
2023-06-16−481,725→ 0 total
Disposition to Issuer
Prometheus Biosciences, Inc.
Stock Option (right to buy)
2023-06-16−566,307→ 0 total
Disposition to Issuer
Prometheus Biosciences, Inc.
Stock Option (right to buy)
2023-06-16−290,000→ 0 total
Disposition to Issuer
Prometheus Biosciences, Inc.
Stock Option (right to buy)
2023-06-16−128,930→ 0 total
Exercise/Conversion
Prometheus Biosciences, Inc.
Common Stock
2023-06-02$2.90/sh+122,528→ 177,672 total
Exercise/Conversion
Prometheus Biosciences, Inc.
Stock Option (Right to Buy)
2023-06-02−3→ 132,741 total
Exercise/Conversion
Prometheus Biosciences, Inc.
Stock Option (Right to Buy)
2023-06-02−122,528→ 161,105 total
Exercise/Conversion
Prometheus Biosciences, Inc.
Common Stock
2023-06-02$1.70/sh+3→ 178,036 total
Sale
Prometheus Biosciences, Inc.
Common Stock
2023-03-15$116.14/sh−25,000→ 55,144 total
Exercise/Conversion
Prometheus Biosciences, Inc.
Common Stock
2023-03-15$2.90/sh+25,000→ 80,144 total
Exercise/Conversion
Prometheus Biosciences, Inc.
Stock Option (Right to Buy)
2023-03-15−25,000→ 283,633 total
Exercise/Conversion
Prometheus Biosciences, Inc.
Common Stock
2023-03-03$3.70/sh+10,620→ 65,764 total
Exercise/Conversion
Prometheus Biosciences, Inc.
Stock Option (Right to Buy)
2023-03-03−10,620→ 481,725 total
Sale
Prometheus Biosciences, Inc.
Common Stock
2023-03-03$125.13/sh−10,620→ 55,144 total
Sale
Prometheus Biosciences, Inc.
Common Stock
2023-03-01$125.26/sh−700→ 55,144 total
Exercise/Conversion
Prometheus Biosciences, Inc.
Stock Option (Right to Buy)
2023-03-01−700→ 492,345 total
Exercise/Conversion
Prometheus Biosciences, Inc.
Common Stock
2023-03-01$3.70/sh+700→ 55,844 total
Sale
Prometheus Biosciences, Inc.
Common Stock
2023-02-17$125.10/sh−13,680→ 55,144 total
Exercise/Conversion
Prometheus Biosciences, Inc.
Stock Option (Right to Buy)
2023-02-17−13,680→ 493,045 total
Exercise/Conversion
Prometheus Biosciences, Inc.
Common Stock
2023-02-17$3.70/sh+13,680→ 68,824 total
Exercise/Conversion
Prometheus Biosciences, Inc.
Common Stock
2023-02-16$3.70/sh+25,000→ 80,144 total

McKenna Mark C.

Recent Transactions

Companies

Recent Filings

Address